Multimedia

Sunday, January 29, 2012

Alex A. Adjei, MD, PhD, Senior Vice President of Clinical Research and Chair of the Department of Medicine, and William Cance, MD, RPCI Surgeon-in-Chief and Co-Founder of CureFAKtor Pharmaceuticals LLC, discuss trends in cancer pharmacotherapy at RPCI and worldwide.